Search Results

Suggested Topics within your search.
Refine Results
  1. 1
    The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia

    The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed... by Paulo Vidal Campregher, Ricardo Helman, Welbert Oliveira Pereira, Renato Puga, Bianca Cristina Garcia Lisbôa, Evelyn Helena Ascendino, Mariana Yasue Saito Miyagi, Sandra Nakashima Yoshida, Isabel Bello, Michelli Silva Diniz, Guilherme Fleury Perini, Tarcila Santos Datoguia, Elvira Deolinda Rodrigues Pereira Velloso, Joao Carlos Guerra, Paulo Augusto Achucarro Silveira, Nydia Strachman Bacal, Roberta Cardoso Petroni, Juliane Musacchio, Rodrigo Santucci, Ana Fernandes Schriefer, Marco Aurélio Salvino, Rodolfo Daniel de Almeida Soares, Manuela Pinto Tibúrcio, Leila Martins Perobelli, Eizabeth Xisto Souto, Danielle Leão Cordeiro de Farias, Marcia Higashi, Adriana Valente Fadel, Carolina Kassab, Leandro Padua, Patricia W Bollman, Denise da Cunha Pasqualin, Alanna Mara Pinheiro Sobreira Bezerra, Marinus de Moraes Lima, Erika MM Costa, Vinicius R. P. Mattos, Fernando Ferreira Costa, Nelson Hamerschlak, Fábio Pires de Souza Santos

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans

    Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans by EM Mazur, AG Rosmarin, PA Sohl, Julia L. Newton, A Narendran

    Published 1992
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay

    Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay by L-Y Shih, Lee Ct

    Published 1994
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Discriminating between essential thrombocythemia and masked polycythemia vera in <i>JAK2</i> mutated patients

    Discriminating between essential thrombocythemia and masked polycythemia vera in <i>JAK2</i> mutated patients by Tiziano Barbui, Jürgen Thiele, Alessandra Carobbio, Paola Guglielmelli, Alessandro Rambaldi, Alessandro M. Vannucchi, Ayalew Tefferi

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    <i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events

    <i>JAK2</i>V617F monitoring in polycythemia vera and essential thrombocythemia: Clinical usefulness for predicting myelofibrotic transformation and thrombotic events by Alberto Álvarez‐Larrán, Beatríz Bellosillo, Arturo Pereira, Ana Kerguelen, Juan Carlos Hernández‐Boluda, Luz Martínez‐Avilés, Concepción Fernández‐Rodríguez, Montse Gómez, Luís Lombardía, Anna Angona, Águeda Ancochea, Alicia Senín, Raquel Longarón, Blanca Navarro, María Collado, Carlos Besses

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Long term treatment of myeloproliferative disease with interferon-?-2b

    Long term treatment of myeloproliferative disease with interferon-?-2b by Harriet S. Gilbert

    Published 1998
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension

    Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension by HS Gilbert, Vincent Praloran, E. Richard Stanley

    Published 1989
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    The 2008 World Health Organization classification system for myeloproliferative neoplasms

    The 2008 World Health Organization classification system for myeloproliferative neoplasms by Ayalew Tefferi, Jüergen Thiele, James W. Vardiman

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders

    Altered arachidonate metabolism by platelets in patients with myeloproliferative disorders by M Okuma, Haruto Uchino

    Published 1979
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Hemorrhagic Thrombocythemia; Control of Postsplenectomy Thrombocytosis with Melphalan

    Hemorrhagic Thrombocythemia; Control of Postsplenectomy Thrombocytosis with Melphalan by Thomas A. Bensinger, Gerald L. Logue, R. Wayne Rundles

    Published 1970
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell

    Evidence that essential thrombocythemia is a clonal disorder with origin in a multipotent stem cell by PJ Fialkow, GB Faguet, RJ Jacobson, K Vaidya, S Murphy

    Published 1981
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera

    The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera by Khadija Abdulkarim, Börje Ridell, Peter Johansson, Jack Kutti, Soodabeh Safai‐Kutti, Björn Andréasson

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia

    Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia by Gabriela M. Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G. Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A. McDevitt, Alexander Röth, Michael Daskalakis, Bart Burington, Monic J. Stuart, David S. Snyder

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    How common are myeloproliferative neoplasms? A systematic review and meta‐analysis

    How common are myeloproliferative neoplasms? A systematic review and meta‐analysis by Glen J. Titmarsh, Andrew Duncombe, Mary Frances McMullin, Michael O’Rorke, Ruben A. Mesa, Frank de Vocht, Sarah Horan, Lin Fritschi, Mary Clarke, Lesley Anderson

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Hemorrhagic Thrombocythemia: A Critical Review

    Hemorrhagic Thrombocythemia: A Critical Review by F. W. Gunz

    Published 1960
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  16. 16
    Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis

    Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosis by Tiziano Barbui, J. Thiele, Alessandro M. Vannucchi, Ayalew Tefferi

    Published 2015
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  17. 17
    Proinflammatory Cytokine IL‐6 and JAK‐STAT Signaling Pathway in Myeloproliferative Neoplasms

    Proinflammatory Cytokine IL‐6 and JAK‐STAT Signaling Pathway in Myeloproliferative Neoplasms by Vladan P. Čokić, Olivera Mitrović Ajtić, Bojana Beleslin‐Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac‐Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Primary myelofibrosis: 2013 update on diagnosis, risk‐stratification, and management

    Primary myelofibrosis: 2013 update on diagnosis, risk‐stratification, and management by Ayalew Tefferi

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis

    The effect of long-term ruxolitinib treatment on JAK2p.V617F allele burden in patients with myelofibrosis by Michael W. Deininger, Jerald P. Radich, Timothy C. Burn, Reid Huber, Dilan Paranagama, Srđan Verstovšek

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Detection of MPL Mutations by a Novel Allele-Specific PCR-Based Strategy

    Detection of MPL Mutations by a Novel Allele-Specific PCR-Based Strategy by Larissa V. Furtado, Helmut C. Weigelin, Kojo S.J. Elenitoba‐Johnson, Bryan L. Betz

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: